Clinical Trials Logo

Bone Neoplasm of Hip (Diagnosis) clinical trials

View clinical trials related to Bone Neoplasm of Hip (Diagnosis).

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03780036 Not yet recruiting - Clinical trials for Bone Neoplasm of Hip (Diagnosis)

Megaprosthetic Implants the Next Generation (MING)

MING
Start date: February 1, 2019
Phase: N/A
Study type: Interventional

This is an interventional randomized controlled trial that will compare patients who underwent segmental hip replacement using mega-implants with either porous collar or porous collar with HA. Patient recruitment will continue for 18 months. Parameters to be investigated are radiographic measures of bone incorporation into the implants, as well as patient functional outcomes. Clinical follow-up will last for 24 months for each patient.

NCT ID: NCT03453905 Not yet recruiting - Bone Metastases Clinical Trials

Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.

ZYCTFEA
Start date: March 1, 2018
Phase: N/A
Study type: Interventional

Patients with metastases to proximal femur, who are evaluated fr the risk of pathologic fracture in order to decide on preventive fixation vs follow-up constitute the study population. The patients will be randomized in two arms. First arm - the decision of treatment will rely on conventional decision algorithm including specialist judgement and Mirels' score. Second arm- the decision on treatment will be supported by CTFEA analysis of bone structure and quantitative simulation-based estimate of fracture risk, in addition to the conventional decision algorithm. Operation rates, pathologic fracture rates and additional secondary outcomes will be compared between the two study arms.